STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump (STAR)

Inclusion Criteria:

-

Study participants must meet all the following criteria:

1. Age ≥18 years old;
2. Implanted with the CH-VAD pump for advanced heart failure, and the CH-VAD pump is the first implanted left ventricular assist device;
3. Able to understand the study purpose, voluntarily participate and sign the informed consent form, and willing to comply with the study procedures and follow-up requirements.

Exclusion Criteria:

-

Study participants meet any of the following criteria will be excluded:

1. Requirement for additional temporary or permanent mechanical circulatory support after LVAD implantation;
2. Requirement for physician-mandated antiplatelet therapy after implantation due to medical history, surgical history, concomitant surgical procedures, or other conditions, including mandated presence or absence of antiplatelet agent;
3. Occurrence of primary endpoint events prior to randomization (within 2-7 days after implantation);
4. Inability to take oral medications post-implant through 7 days;
5. Known allergy to aspirin;
6. Participation in another clinical investigation that may affect study outcome;
7. Presence of other comorbid conditions, social or psychological conditions, or other conditions, in the investigator's opinion, that may affect participation in the study or compliance with follow-up requirements.